Skip to content

A safety and efficacy evaluation of a female intimate wash product

A Study to Evaluate the Safety and Efficacy Of Female Intimate Wash Product in Maintaining a Healthy pH and Microflora in Healthy Indian Women.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024457
Enrollment
35
Registered
2020-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Feminine Intimate Wash product: As per investigator direction,Topical Application of the product for 28 days Control Intervention1: Control: As per investigator direction for 84 days

Sponsors

ITC Life Sciences and Technology Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy women in the age group of 18- 55 years. 2. Atleast one instance of UTI in the past 6 months. 3. Women willing to abide by the study protocol and study restrictions including abstinence from: use of any other product besides the allotted product during the study course, changing their usual brand of sanitary products and laundry detergents during the study course,showering/ bathing / cleaning their genitals with the test product on the day of study visit,depilation of pubic hair through topical products/waxing/ shaving (Trimming with scissors allowed)during the study course,oral or topical Anti-biotic/ Anti mycotic/Anti inflammatory medicine or OTC / products without informing to the study investigator.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or lactating 2. Women with a known history or present condition of allergic response to any cosmetic products/ fragranced product which may influence the study result. 3. Women with bacterial vaginosis/ candidiasis/ mycotic infections / active psoriasis/ eczema/ other active skin disorder / any form of chronic infection / allergy / disease which may influence the study result. 4. Women in the post menopausal age group 5. Women with vulvo-vaginal dryness 6. Women who are currently taking or had taken antibiotics course in the past 3 months 7. Women who have changed the contraceptive medications or Menopausal / Hormonal treatment in the past 3 months or are contemplating to do so.

Design outcomes

Primary

MeasureTime frame
Safety of Feminine Intimate Wash productTimepoint: Day 0, Day 28

Secondary

MeasureTime frame
Efficacy of the Feminine Intimate Wash productTimepoint: Day 0, Day 28

Countries

India

Contacts

Public ContactJestin V Thomas

Leads Clinical Research and Bio Services Pvt. Ltd

jestin.leadsclinbio@gmail.com9845125293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026